Efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in nasopharyngeal carcinoma in vitro and in vivo
Abstract Background Tumor hypoxia is considered an important factor in metastasis and disease relapse. Evofosfamide is a hypoxia-activated prodrug that selectively targets the hypoxic regions of solid tumors. As hypoxia-inducible factor-1α (HIF-1α) is overexpressed in nasopharyngeal carcinoma (NPC)...
Main Authors: | Yan Huang, Ying Tian, Yuanyuan Zhao, Cong Xue, Jianhua Zhan, Lin Liu, Xiaobo He, Li Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-05-01
|
Series: | Cancer Communications |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40880-018-0285-0 |
Similar Items
-
The Hypoxia-Activated Prodrug TH-302: Exploiting Hypoxia in Cancer Therapy
by: Yue Li, et al.
Published: (2021-04-01) -
Mechanism of HIF-1α Promoting Malignant Development of Nasopharyngeal Carcinoma by Upregulating PD-L1 Under Hypoxic Conditions
by: JIANG Doudou, et al.
Published: (2021-06-01) -
Hypoxia and Hypoxia-Inducible Factor Signaling in Muscular Dystrophies: Cause and Consequences
by: Thuy-Hang Nguyen, et al.
Published: (2021-07-01) -
Efforts to overcome hypoxia condition in Balb/c mouse macrophages after intraperitoneal SRBC immunization
by: Pungguri Ayu Nega Sarsanti, et al.
Published: (2019-05-01) -
Regulation of the Hypoxia-Inducible Factor (HIF) by Pro-Inflammatory Cytokines
by: Mykyta I. Malkov, et al.
Published: (2021-09-01)